Zobrazeno 1 - 10
of 38
pro vyhledávání: '"V M, Fomina"'
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 13, Iss 6, Pp 841-850 (2017)
Advantages of amlodipine, lisinopril and their fixed-dose combination are presented regarding to antihypertensive effect and target-organs protection in patients with arterial hypertension in the presence of obesity. Abnormalities in myocardial strai
Externí odkaz:
https://doaj.org/article/a06050ebaa5c4defbaca5e205c9e4b78
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 13, Iss 5, Pp 693-698 (2017)
The main mechanisms by which obesity and overweight exacerbate heart damage as a target-organ of arterial hypertension (HT), and also increase the risk of cardiovascular complications are discussed. Features of the daily profile of blood pressure and
Externí odkaz:
https://doaj.org/article/04a92682126a4ece9b4a07e331672498
Publikováno v:
Системные гипертензии, Vol 13, Iss 1, Pp 6-10 (2016)
The article focuses on the use of b-blockers for the treatment of arterial hypertension (AH). Given the situation of modern Russian and European recommendations about the place of b-blockers in the treatment of AH, including their benefits with a com
Externí odkaz:
https://doaj.org/article/c5ccfb90e1f34efebe27a8d66a0630c8
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 7, Iss 5, Pp 620-627 (2016)
The world publications data about the impact of consumption and the fatty acids ratio in consumed fats on the development of cardiovascular diseases and acute complications due to atherothrombosis is presented. The role of some fat characteristics is
Externí odkaz:
https://doaj.org/article/c82d5f1970584665b0382226cc04ed82
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 8, Iss 6, Pp 798-803 (2015)
Advantages of metoprolol succinate in patients with chronic heart failure (CHF) are covered. Results of MERIT-HF study are taken as the main evidences. Patterns of the metoprolol succinate use in the treatment of different categories of patients with
Externí odkaz:
https://doaj.org/article/308c14a5089d4d8e9785b4b17ab146ce
Publikováno v:
Системные гипертензии, Vol 12, Iss 4, Pp 69-74 (2015)
In the article discusses questions of application of b-blockers (b-AB) for the treatment of arterial hypertension, coronary heart disease, chronic heart failure. The data from modern Russian and European recommendations about the place of b-AB in the
Externí odkaz:
https://doaj.org/article/4bec5793950a4cf7884521a5b67e05d3
Autor:
O. D. Ostroumova, V. M. Fomina
Publikováno v:
Медицинский совет, Vol 0, Iss 12, Pp 72-77 (2015)
The article tells about the mechanisms of action of beta-blockers. Pharmacokinetic, pharmacodynamic and interaction properties of metoprolol are discussed. Findings on the efficacy and safety of metoprolol succinate and metoprolol tartrate in arteria
Externí odkaz:
https://doaj.org/article/c0c7962e0905418b8a7c947ebcee2b65
Publikováno v:
Системные гипертензии, Vol 12, Iss 1, Pp 70-75 (2015)
This article deals with the epidemiological datashowing higher frequency of arterial hypertension (AH) in patients with ischemic heart disease (IHD). We discussed the basic characteristics of modern domestic and foreign recommendations for treating p
Externí odkaz:
https://doaj.org/article/3c40308dc21f434ba06e63ab2684d330
Publikováno v:
Медицинский совет, Vol 0, Iss 9, Pp 44-49 (2013)
The article focuses on differential choice of ACE inhibitor in clinical practice. Mechanisms of action common for all drugs in this group, indications and benefits are described. Differences in pharmacokinetic features, RAAS blockade, additional uniq
Externí odkaz:
https://doaj.org/article/b79093881f5b408792f414d7d129f4fe
Publikováno v:
Системные гипертензии, Vol 8, Iss 4, Pp 16-21 (2011)
Externí odkaz:
https://doaj.org/article/fd0d402f0d424b3c804c80e20386f50b